These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9379116)

  • 1. Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis.
    Dempster DW; Moonga BS; Stein LS; Horbert WR; Antakly T
    J Endocrinol; 1997 Sep; 154(3):397-406. PubMed ID: 9379116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones.
    Tobias J; Chambers TJ
    Endocrinology; 1989 Sep; 125(3):1290-5. PubMed ID: 2759026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.
    Weinstein RS; Chen JR; Powers CC; Stewart SA; Landes RD; Bellido T; Jilka RL; Parfitt AM; Manolagas SC
    J Clin Invest; 2002 Apr; 109(8):1041-8. PubMed ID: 11956241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of glucocorticoid on recruitment and activity of osteoclasts induced by normal and osteocalcin-deficient bone implanted in rats.
    Defranco DJ; Lian JB; Glowacki J
    Endocrinology; 1992 Jul; 131(1):114-21. PubMed ID: 1611989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
    Frith JC; Mönkkönen J; Auriola S; Mönkkönen H; Rogers MJ
    Arthritis Rheum; 2001 Sep; 44(9):2201-10. PubMed ID: 11592386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids suppress bone formation via the osteoclast.
    Kim HJ; Zhao H; Kitaura H; Bhattacharyya S; Brewer JA; Muglia LJ; Ross FP; Teitelbaum SL
    J Clin Invest; 2006 Aug; 116(8):2152-60. PubMed ID: 16878176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
    Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro.
    Gronowicz G; McCarthy MB; Raisz LG
    J Bone Miner Res; 1990 Dec; 5(12):1223-30. PubMed ID: 2127506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms.
    Brandi ML; Hukkanen M; Umeda T; Moradi-Bidhendi N; Bianchi S; Gross SS; Polak JM; MacIntyre I
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2954-8. PubMed ID: 7535933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucocorticoids on Fas gene expression in bovine blood neutrophils.
    Chang LC; Madsen SA; Toelboell T; Weber PS; Burton JL
    J Endocrinol; 2004 Dec; 183(3):569-83. PubMed ID: 15590983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
    Swanson C; Lorentzon M; Conaway HH; Lerner UH
    Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption.
    Alam AS; Gallagher A; Shankar V; Ghatei MA; Datta HK; Huang CL; Moonga BS; Chambers TJ; Bloom SR; Zaidi M
    Endocrinology; 1992 Jun; 130(6):3617-24. PubMed ID: 1597159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro.
    Gohel A; McCarthy MB; Gronowicz G
    Endocrinology; 1999 Nov; 140(11):5339-47. PubMed ID: 10537165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glucocorticoid-induced changes of Na(+), K(+)-ATPase in rat lens by a glucocorticoid receptor antagonist RU486.
    Xie GL; Yan H; Lu ZF
    Exp Eye Res; 2010 Oct; 91(4):544-9. PubMed ID: 20637751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective toxic effects of tamoxifen on osteoclasts: comparison with the effects of oestrogen.
    Arnett TR; Lindsay R; Kilb JM; Moonga BS; Spowage M; Dempster DW
    J Endocrinol; 1996 Jun; 149(3):503-8. PubMed ID: 8691109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.
    Jia D; O'Brien CA; Stewart SA; Manolagas SC; Weinstein RS
    Endocrinology; 2006 Dec; 147(12):5592-9. PubMed ID: 16935844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.